AAMP Inhibitors are a specialized class of chemical compounds designed to target and inhibit the AAMP (Angio-Associated Migratory Cell Protein), a protein implicated in various cellular processes, including cell migration and signal transduction. These inhibitors function by binding to specific regions of the AAMP protein, disrupting its normal conformation or interfering with its interactions with other proteins and cellular components. The binding of AAMP Inhibitors is typically characterized by a high degree of specificity, achieved through the careful design of the inhibitor's molecular structure to match the unique binding sites on the AAMP protein. This interaction can cause conformational changes that either block the protein's active sites or alter its ability to participate in essential cellular pathways, effectively modulating its activity. The precision of these inhibitors in targeting AAMP is often the result of detailed studies into the protein's structure and function, allowing for the development of compounds that can selectively and effectively bind to the target protein.
The chemical characteristics of AAMP Inhibitors, such as their molecular weight, solubility, and stability, are crucial in determining their ability to interact effectively with the AAMP protein under various physiological conditions. These inhibitors often incorporate a blend of hydrophobic and hydrophilic regions, which facilitate their interaction with different parts of the protein, including non-polar binding sites and polar residues. The presence of specific functional groups, such as aromatic rings, hydroxyl groups, or amines, can enhance binding through mechanisms like π-π interactions, hydrogen bonding, or electrostatic attractions. Additionally, the binding kinetics, including how quickly and strongly the inhibitor binds to and dissociates from the AAMP protein, play a significant role in the efficacy of the inhibition process. By exploring the interactions between AAMP Inhibitors and their target, researchers can gain a deeper understanding of the molecular dynamics that govern cell migration and signal transduction, offering insights into the fundamental processes that maintain cellular structure and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
RAF inhibitor that can impact signaling cascades influencing AAMP-related cell migration. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $197.00 $520.00 $1093.00 | 4 | |
Tyrosine kinase inhibitor that can disrupt pathways associated with AAMP and angiogenesis. | ||||||
TNP 470 | 129298-91-5 | sc-296547 | 10 mg | $235.00 | ||
Angiogenesis inhibitor that can affect endothelial cell migration where AAMP is implicated. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Inhibits angiogenesis and related signaling, likely influencing AAMP's associated processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can affect cell migration and angiogenesis, processes involving AAMP. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect signaling pathways relevant to AAMP's role in cell migration. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can alter MAPK/ERK pathway, potentially impacting AAMP's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can disrupt signaling pathways associated with AAMP's role in cell dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can disrupt cellular processes in which AAMP is involved. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Inhibitor of collagen type I synthesis and TGF-β signaling, affecting AAMP-related pathways. | ||||||